$310.20
+$7.35(+2.42%)
*Data last updated: 2026-06-18 18:24 (UTC+8)
As of 2026-06-18 18:24, Stryker Corp (SYK) is priced at $310.20, with a total market cap of $115.44B, a P/E ratio of 41.38, and a dividend yield of 1.14%. Today, the stock price fluctuated between $299.30 and $318.10. The current price is 3.64% above the day's low and 2.48% below the day's high, with a trading volume of 1.73M. Over the past 52 weeks, SYK has traded between $281.00 to $367.34, and the current price is -15.55% away from the 52-week high.
SYK Key Stats
Yesterday's Close$310.58
Market Cap$115.44B
Volume1.73M
P/E Ratio41.38
Dividend Yield (TTM)1.14%
Dividend Amount$0.88
Diluted EPS (TTM)8.71
Net Income (FY)$3.24B
Revenue (FY)$25.11B
Earnings Date2026-07-30
EPS Estimate3.49
Revenue Estimate$6.58B
Shares Outstanding371.70M
Beta (1Y)0.785
Ex-Dividend Date2026-06-30
Dividend Payment Date2026-07-31
About SYK
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
SectorHealthcare
IndustryMedical - Devices
CEOKevin A. Lobo
HeadquartersPortage,MI,US
Official Websitehttps://www.stryker.com
Employees (FY)56.00K
Average Revenue (1Y)$448.50K
Net Income per Employee$57.96K
Stryker Corp (SYK) FAQ
What's the stock price of Stryker Corp (SYK) today?
x
Stryker Corp (SYK) is currently trading at $310.20, with a 24h change of +2.42%. The 52-week trading range is $281.00–$367.34.
What are the 52-week high and low prices for Stryker Corp (SYK)?
x
What is the price-to-earnings (P/E) ratio of Stryker Corp (SYK)? What does it indicate?
x
What is the market cap of Stryker Corp (SYK)?
x
What is the most recent quarterly earnings per share (EPS) for Stryker Corp (SYK)?
x
Should you buy or sell Stryker Corp (SYK) now?
x
What factors can affect the stock price of Stryker Corp (SYK)?
x
How to buy Stryker Corp (SYK) stock?
x
Risk Warning
The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.






